| 英文名称 |
(8S,9S,10R,11S,13S,14S,16R,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl butyrate
|
| 英文别名 |
Imp. I (EP): 11 ,17,21-Trihydroxy-3,20-dioxopregna-1,4-dien-16 -yl Butanoate;16α-Butyloxyprednisolone (Budenoside Impurity);16α-Butyloxyprednisolone
(Budenoside Impurity);Budesonide Impurity I;Budesonide EP Impurity I;Budenoside Impurity I(EP);16±-Butyloxyprednisolone\n(Budenoside Impurity);11β,17,21-trihydroxy-3,20-dioxopregna-1,4-dien-16α-yl butanoate
|
| 详情描述 |
仅用于研发试验中鉴别、检查。113930-13-5|布地奈德杂质09对照品,制备中,详情请联系Medlife客服进行咨询。(8S,9S,10R,11S,13S,14S,16R,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl butyrate可放大生产,批量保障。
|